top of page
Events
SLC6A1 SWITZERLAND ANNUAL MEETING: APARTHOTEL AL LAGO, LOCARNO, 8 MARCH 2026
Exactly one year after its foundation, the first SLC6A1 Switzerland annual meeting took place.
It was attended by families of people affected by the disease, supporters, experts, researchers and representatives from the pharmaceutical industry.
The agenda of the meeting was as follows:
SLC6A1 Switzerland: mission, activities and current projects, Locarno, 8 March 2026
Dr Thomas Dorn – committee member of the Swiss Society for Health in Intellectual Disability (SSHID), 8 March 2026
Prof. Elena Bossi – Associate Professor of Physiology, University of Insubria, Varese (Italy), 8 March 2026
Raffaele De Rosa – Member of the State Council, Department of Health and Social Affairs, Canton Ticino
Tiziana Romanazzi – Researcher in Physiology, University of Insubria, Varese (Italy)
Dr Georgia Ramantani – Senior Consultant, Paediatric Neurology (EEG/Epilepsy), Zurich Children’s Hospital, 8 March 2026
Dr Ganna Balagura – Doctor and researcher, IRCCS Giannina Gaslini Institute, Genoa (Italy), 8 March 2026
Cosimo Mazzotta – President, ATGABBES, March 8, 2026
FIRST EUROPEAN SYMPOSIUM ON THE SLC6A1 MUTATION
Lisbon, Portugal – August 29, 2025
Our first European SLC6A1 Symposium, organized with our sister organization CURE GABA-A, was a high-level scientific event.
Speakers shared key updates and future research perspectives.
Dr. Sebastian Silva-Soto MD, Filadelfia, Danish Epilepsy Center, Denmark
Updating the international SLC6A1 Patients Database
Dr. Katrine M.Johannesen, MD, PhD, Filadelfia, Danish Epilepsy Center, Denmark
Understanding the SLC6A1 phenotype
Lecturer in Neuropharmacology, School of Pharmacy, Newcastle University
From Network Disruption to Funcional Recovery: Modelling Rare Disorders with Human iPSC Models
Professor Nick Lench, PhD
Executive Director, MRC/UKRI Nucleic Acid Therapy Accelerator (NATA)
Oligonucleotide Therapy Development
Elena Bossi, PhD
Associate Professor of Physiology, Department of Biotechnology and Life Sciences, University of Insubria
Building a European Scientific Network
Sarah Poliquin, PhD
Postdoctoral Fellow at COMBINEDBrain, Chief Scientific Officer of Cure GABA-A
Participate in real Research! The importance of Sharing your Data
Antonella Riva, M.D., Greta Volpedo, Ph.D.
Università degli studi di Genova, Italy
Identification of an epilepsy-linked gut microbiota signature
bottom of page